TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/19/24 08:31 | 7/17/24 | CADL | Candel Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tyagarajan Seshu | MA | O | CTO | S | -96 | 6.47 | 0 | -15 | -9 | 146 | D | ||||||||||||||
7/15/24 08:36 | 7/11/24 | CADL | Candel Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tyagarajan Seshu | MA | O | CTO | S | -80 | 5.97 | 0 | -13 | -8 | 161 | D | ||||||||||||||
12/12/22 16:25 | 12/8/22 | CADL | Candel Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tyagarajan Seshu | MA | O | CTO | P.m | 25 | 1.88 | 0 | 13 | New | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |